Archive for the ‘Latest News’

Your Opinion is Requested… Care Outcome Set for Headache (COSH) Study

1702-1252709341CgRp
21st June 2017

The Core Outcome Set for Headache (COSH) Study: working towards agreement on what should be measured in headache research studies Understanding the way in which headaches affect people and the potential benefits of treatment is important. However, there is currently no guidance for how best to do this and a wide range of approaches are used. These approaches to assessment are called outcomes or outcome measures - you may have experience of... [read more]


Migraine Book

migraine-book-cover
7th April 2017

Our book, Migraine Not Just Another Headache, is now available to buy from local bookshops and from our website.  Written by experts, this book describes the role of the GP, nurse, pharmacist, paediatrician, physiotherapist and psychologist in the treatment of migraine. It advises about the management of migraine in the home, at school, in the sports centre and workplace. It gives crucial information from neurology and from specialist... [read more]


CGRP antibodies & migraine – findings so far

PGEAN
10th March 2017

CGRP (Calcitonin Gene Related Peptide) is a neuropeptide which is released into the blood stream during a migraine attack and it has a central role in the underlying mechanisms of a migraine attack. Recent results from clinical trials targeting CGRP are encouraging and the drugs are now entering phase 3 late stage clinical trials to further evaluate the benefits and safety of these new therapies. In this video clip at the European Academy... [read more]


New HSE toolkit on the use of sodium valproate (Epilim)

Migraine
11th October 2016

The HSE has published a new toolkit on the drug sodium valproate (Epilim) for patients and prescribers. The Valproate toolkit was produced by the National Clinical Programmes for Epilepsy, Mental Health and Medicines Management in consultation with the HPRA and patient groups. It aims to reinforce the safety message for healthcare professionals and patients that valproate is not prescribed for girls or women of child-bearing age unless... [read more]


National Clinical Programme for Neurology launched

neurology-moc-cover-2
27th September 2016

The Migraine Association of Ireland welcomes the launch of a detailed framework to guide the development of neurology services in Ireland.  The model of care, launched on 27th September 2016 by the National Clinical Programme for Neurology, provides a comprehensive blueprint for the design and delivery of neurology services in acute hospitals and the ongoing management of the needs of people with neurological conditions in the community. The... [read more]


Archive for the ‘Latest News’

Your Opinion is Requested… Care Outcome Set for Headache (COSH) Study

1702-1252709341CgRp
21st June 2017

The Core Outcome Set for Headache (COSH) Study: working towards agreement on what should be measured in headache research studies Understanding the way in which headaches affect people and the potential benefits of treatment is important. However, there is currently no guidance for how best to do this and a wide range of approaches are used. These approaches to assessment are called outcomes or outcome measures - you may have experience of... [read more]


Migraine Book

migraine-book-cover
7th April 2017

Our book, Migraine Not Just Another Headache, is now available to buy from local bookshops and from our website.  Written by experts, this book describes the role of the GP, nurse, pharmacist, paediatrician, physiotherapist and psychologist in the treatment of migraine. It advises about the management of migraine in the home, at school, in the sports centre and workplace. It gives crucial information from neurology and from specialist... [read more]


CGRP antibodies & migraine – findings so far

PGEAN
10th March 2017

CGRP (Calcitonin Gene Related Peptide) is a neuropeptide which is released into the blood stream during a migraine attack and it has a central role in the underlying mechanisms of a migraine attack. Recent results from clinical trials targeting CGRP are encouraging and the drugs are now entering phase 3 late stage clinical trials to further evaluate the benefits and safety of these new therapies. In this video clip at the European Academy... [read more]


New HSE toolkit on the use of sodium valproate (Epilim)

Migraine
11th October 2016

The HSE has published a new toolkit on the drug sodium valproate (Epilim) for patients and prescribers. The Valproate toolkit was produced by the National Clinical Programmes for Epilepsy, Mental Health and Medicines Management in consultation with the HPRA and patient groups. It aims to reinforce the safety message for healthcare professionals and patients that valproate is not prescribed for girls or women of child-bearing age unless... [read more]


National Clinical Programme for Neurology launched

neurology-moc-cover-2
27th September 2016

The Migraine Association of Ireland welcomes the launch of a detailed framework to guide the development of neurology services in Ireland.  The model of care, launched on 27th September 2016 by the National Clinical Programme for Neurology, provides a comprehensive blueprint for the design and delivery of neurology services in acute hospitals and the ongoing management of the needs of people with neurological conditions in the community. The... [read more]